Virtus ETF Advisers’s FibroGen FGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-241
Closed -$5.21K 443
2023
Q3
$5.21K Sell
241
-24
-9% -$519 ﹤0.01% 434
2023
Q2
$17.9K Sell
265
-3
-1% -$203 0.01% 435
2023
Q1
$125K Sell
268
-104
-28% -$48.6K 0.07% 325
2022
Q4
$149K Sell
372
-94
-20% -$37.6K 0.08% 347
2022
Q3
$152K Buy
466
+3
+0.6% +$979 0.06% 351
2022
Q2
$122K Buy
463
+1
+0.2% +$263 0.05% 380
2022
Q1
$139K Sell
462
-27
-6% -$8.12K 0.06% 240
2021
Q4
$172K Buy
489
+160
+49% +$56.3K 0.07% 272
2021
Q3
$84K Sell
329
-18
-5% -$4.6K 0.04% 388
2021
Q2
$231K Buy
347
+74
+27% +$49.3K 0.1% 240
2021
Q1
$237K Buy
273
+4
+1% +$3.47K 0.1% 297
2020
Q4
$249K Sell
269
-54
-17% -$50K 0.1% 314
2020
Q3
$332K Sell
323
-44
-12% -$45.2K 0.17% 202
2020
Q2
$372K Buy
367
+59
+19% +$59.8K 0.18% 227
2020
Q1
$268K Sell
308
-45
-13% -$39.2K 0.11% 243
2019
Q4
$378K Buy
353
+104
+42% +$111K 0.06% 278
2019
Q3
$230K Sell
249
-14
-5% -$12.9K 0.05% 222
2019
Q2
$297K Sell
263
-11
-4% -$12.4K 0.06% 218
2019
Q1
$372K Sell
274
-33
-11% -$44.8K 0.79% 41
2018
Q4
$355K Sell
307
-14
-4% -$16.2K 0.06% 88
2018
Q3
$487K Sell
321
-228
-42% -$346K 0.05% 128
2018
Q2
$860K Sell
549
-181
-25% -$284K 0.76% 16
2018
Q1
$844K Buy
730
+388
+113% +$449K 0.73% 66
2017
Q4
$405K Sell
342
-109
-24% -$129K 0.51% 51
2017
Q3
$607K Buy
451
+41
+10% +$55.2K 0.08% 78
2017
Q2
$331K Sell
410
-140
-25% -$113K 0.05% 97
2017
Q1
$339K Buy
550
+53
+11% +$32.7K 0.06% 126
2016
Q4
$266K Sell
497
-98
-16% -$52.5K 0.08% 125
2016
Q3
$308K Hold
595
0.15% 97
2016
Q2
$244K Buy
595
+266
+81% +$109K 0.18% 96
2016
Q1
$175K Buy
+329
New +$175K 0.24% 105